Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.

Habers GE, Huber AM, Mamyrova G, Targoff IN, O'Hanlon TP, Adams S, Pandey JP, Boonacker C, van Brussel M, Miller FW, van Royen-Kerkhof A, Rider LG; Childhood Myositis Heterogeneity Study Group.

Arthritis Rheumatol. 2016 Mar;68(3):761-8. doi: 10.1002/art.39466.

PMID:
26474155
2.

Biomechanical characteristics, patient preference and activity level with different prosthetic feet: a randomized double blind trial with laboratory and community testing.

Raschke SU, Orendurff MS, Mattie JL, Kenyon DE, Jones OY, Moe D, Winder L, Wong AS, Moreno-Hernández A, Highsmith MJ, J Sanderson D, Kobayashi T.

J Biomech. 2015 Jan 2;48(1):146-52. doi: 10.1016/j.jbiomech.2014.10.002. Epub 2014 Oct 14.

3.

Activated STING in a vascular and pulmonary syndrome.

Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Montealegre Sanchez GA, Tenbrock K, Wittkowski H, Jones OY, Kuehn HS, Lee CC, DiMattia MA, Cowen EW, Gonzalez B, Palmer I, DiGiovanna JJ, Biancotto A, Kim H, Tsai WL, Trier AM, Huang Y, Stone DL, Hill S, Kim HJ, St Hilaire C, Gurprasad S, Plass N, Chapelle D, Horkayne-Szakaly I, Foell D, Barysenka A, Candotti F, Holland SM, Hughes JD, Mehmet H, Issekutz AC, Raffeld M, McElwee J, Fontana JR, Minniti CP, Moir S, Kastner DL, Gadina M, Steven AC, Wingfield PT, Brooks SR, Rosenzweig SD, Fleisher TA, Deng Z, Boehm M, Paller AS, Goldbach-Mansky R.

N Engl J Med. 2014 Aug 7;371(6):507-18. doi: 10.1056/NEJMoa1312625. Epub 2014 Jul 16.

4.

Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Rider LG, Katz JD, Jones OY.

Rheum Dis Clin North Am. 2013 Nov;39(4):877-904. doi: 10.1016/j.rdc.2013.06.001. Epub 2013 Sep 19. Review.

5.

Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.

Mamyrova G, Katz JD, Jones RV, Targoff IN, Lachenbruch PA, Jones OY, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2013 Dec;65(12):1969-75. doi: 10.1002/acr.22088.

6.

The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jul;92(4):223-43. doi: 10.1097/MD.0b013e31829d08f9.

7.

Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.

Shah M, Targoff IN, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Rheum. 2013 Jul;65(7):1934-41. doi: 10.1002/art.37985.

8.

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.

9.

Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.

Arabshahi B, Silverman RA, Jones OY, Rider LG.

J Pediatr. 2012 Mar;160(3):520-2. doi: 10.1016/j.jpeds.2011.11.057. Epub 2012 Jan 13.

10.

Parents' perception of self-advocacy of children with myositis: an anonymous online survey.

Katz JD, Mamyrova G, Agarwal S, Jones OY, Bollar H, Huber AM, Rider LG, White PH.

Pediatr Rheumatol Online J. 2011 Jun 7;9(1):10. doi: 10.1186/1546-0096-9-10.

11.

Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes.

Jones OY, Gok F, Rushing EJ, Horkayne-Szakaly I, Ahmed AA.

Stem Cells Cloning. 2011 Dec 9;4:73-8. doi: 10.2147/SCCAA.S23014. eCollection 2011.

12.

Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Wu L, Mamyrova G, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group.

Rheumatology (Oxford). 2010 Dec;49(12):2381-90. doi: 10.1093/rheumatology/keq277. Epub 2010 Aug 27.

13.

Long-term follow-up after non-myeloablative transplant of bone and marrow in BXSB mice.

Jones OY, Lacson A, Zeng X, Jones JM, Katti K, Cahill RA, Ahmed AA.

Lupus. 2009 Aug;18(9):813-21. doi: 10.1177/0961203309104391.

PMID:
19578106
14.

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH; Pediatric Rheumatology Collaborative Study Group.

Arthritis Rheum. 2008 May;58(5):1496-504. doi: 10.1002/art.23427.

15.

Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis.

Jones OY, Cahill RA.

Immunol Res. 2008;41(1):26-33. doi: 10.1007/s12026-007-0015-1. No abstract available.

PMID:
18360745
16.

Comparison of treatment-response criteria for juvenile idiopathic arthritis.

Jones OY, Lovell DJ.

Nat Clin Pract Rheumatol. 2006 Sep;2(9):466-7. No abstract available.

PMID:
16951697
17.

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH; Pediatric Rheumatology Collaborative Study Group.

Arthritis Rheum. 2006 Jun;54(6):1987-94.

18.

A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis.

Jones OY, Spencer CH, Bowyer SL, Dent PB, Gottlieb BS, Rabinovich CE.

Pediatrics. 2006 May;117(5):e840-4.

PMID:
16651289
19.

Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis.

Mirkinson LJ, Nagle D, Kadom N, Jones OY.

J Clin Rheumatol. 2006 Apr;12(2):83-6. Erratum in: J Clin Rheumatol. 2006 Jun;12(3):113.

PMID:
16601542
20.

Stem-like cells traffic from heart ex vivo, expand in vitro, and can be transplanted in vivo.

Steele A, Jones OY, Gok F, Marikar Y, Steele P, Chamizo W, Scott M, Boucek RJ Jr.

J Heart Lung Transplant. 2005 Nov;24(11):1930-9.

PMID:
16297801
Items per page

Supplemental Content

Loading ...
Write to the Help Desk